VSCCs. 3 Early studies of DHPs such as nifedipine demonstrated the ability of these agents to potently block VSCCs, and hence they were described as calcium channel antagonists. 4 A more recently discovered group of DHPs including Bay K 8644, CGP 28 392, and (+)-202-791, which can enhance rather than inhibit calcium current (IcJ, have been referred to as calcium channel agonists. 5 -7 One striking feature of the blocking action of DHP calcium channel antagonists is the voltage dependence of this effect. A 1,000-fold more potent block of VSCCs by some of these agents at depolarized compared with hyperpolarized membrane potentials has been observed electrophysiologically. 8 - 10 Similarly, the binding of calcium channel antagonists has been found to be voltage-dependent.''-' 3 Given the marked voltage dependence of the actions of DHP calcium channel antagonists, it is not surprising that an initial study found that the action of the DHP calcium channel agonist Bay K 8644 was voltage-dependent. M Bay K 8644 was found to greatly enhance I c and contractility in calf Purkinje fibers when the holding potential was hyperpolarized, but Bay K 8644 actually blocked I c and inhibited contractility at depolarized holding potentials. Further studies employing racemic Bay K 8644 and racemic CGP 28 392 confirmed the voltage-dependent actions of DHP calcium channel agonists. 1316 An additional characteristic of the modulation of VSCCs by DHP calcium channel agonists is that a bell shaped concentration effect relation is often observed. Lower concentrations result in a substantial enhancement of I c and calcium dependent phenomena, while higher concentrations result in less agonism or even block. 1718 In addition, certain supposed DHP calcium channel antagonists such as nitrendipine or nimodipine are capable of slightly but reproducibly enhancing Ic 1 9 and increasing cardiac contractility 17 - 18 at low concentrations while block occurs at higher concentrations. Such dual effects of individual DHPs are interesting, but more recent evidence brought these findings into question when it was shown that the stereoisomers of a given DHP such as Bay K 8644 or 202-791 can have strikingly opposite effects. 720 - 22 Could the earlier findings simply be explained by the presence of two enantiomers acting in opposite fashions?
The purpose of the present study was to examine the electrophysiological action of the DHP agonist enantiomer (+)-202-791 on cardiac VSCCs, emphasizing the voltage dependence of these interactions. Also, the related phenomena of use dependence was examined because this has been found to be an important factor in describing the action of racemic Bay K 8644 and racemic CGP 28 392 . 1516 Lastly, the effects of various combinations of the two enantiomers of 202-791 were examined for evidence of cooperative interactions between the enantiomers as suggested by a previous single channel study. 11 The results demonstrated striking voltage-and use-dependent effects of the DHP calcium channel agonist (+)-202-791. This "agonist" enantiomer was shown to be capable of either enhancing or blocking IB. depending on the holding potential and the frequency of stimulation. The blocking action of this compound was most prominent at depolarized potentials and higher rates of stimulation. No evidence of cooperative interactions between the two enantiomers of 202-791 was obtained. A preliminary report of this work has appeared. 23 
Materials and Methods

Isolation of Guinea Pig Ventricular Myocytes
Guinea-pig ventricular myocytes were isolated by the procedure of Mitra and Morad, 1985 . 24 Briefly, hearts were removed from male or female guinea pigs (200-300 g) and perfused in a retrograde fashion via the aorta with a Langendorff perfusion apparatus. The heart was perfused at 10 ml/min with the following oxygenated solutions at 37° C: 1) nominally calcium free salt solution containing (mM) NaCl 132, KC1 4.8, MgCl 2 1.2, glucose 5, and HEPES 10 (pH 7.2) for 5 minutes; 2) nominally free calcium salt solution plus 150-300 IU/ml collagenase (Type II, Worthington) and 0.02% protease type XIV (Sigma Chemical Co, St. Louis, Missouri) for 8 minutes; 3) 0.2 mM Ca salt solution as above without any enzymes for 5 minutes. The ventricles were then cut into several approximately 3x3 mm pieces, and each piece placed in a beaker with 10 ml of the 0.2 Ca salt solution and gently shaken at 37° C for 5 minutes to disperse the isolated cells. Any undigested pieces of tissue were removed, and CaCl 2 was added to raise the [Ca] to 2.0 mM. Gentamycin was added to inhibit bacterial growth at a final concentration of 50 /ig/ml. The isolated cells were then maintained at 20-22° C in the described buffer until use within 48 hours of isolation.
Whole-Cell, Patch-Clamp Studies
Whole-cell, voltage-clamp currents were measured according to Hamill et al. 25 These experiments were carried out at 20-22° C. Single cells were placed in a small chamber (0.2 ml) and perfused with the HEPES-buffered salt solution described above. The pipette contained (mM) CsCl 65, CsOH 60, aspartate 55, MgCl 2 1, EGTA 11, CaCl 2 1, MgATP 2, Tris 2 phosphocreatine 5, and HEPES 10 (pH 7.3 with CsOH). On attainment of a high resistance seal ( s i gigafl) and a breaking through of the cell membrane, the chamber was perfused continuously (1-2 ml/min) during the recording period with a solution containing (mM) CaCl 2 1.8 or BaCl 2 1.8, TrisCl 132, CsCl 4.8, MgCl 2 1.2, tetrodotoxin 0.03, and HEPES 10 (pH 7.4). The pipette and bath solutions were chosen to isolate IB, or Ic, from sodium and potassium currents. Series resistance was compensated after the seal was broken to provide the fastest capacity transient possible without ringing of the amplifier. Currents were filtered with an eight-pole Bessel filter at a cutoff frequency of 3 kHz. The records were digitized with an IBM AT computer system using the pClamp software package versions 3.0 and 4.0 (Axon Instruments, Burlingame, California).
Barium was used as the charge carrier for the vast majority of the experiments due to a greater stability of the currents in barium compared with calcium, as has been noted by others. 26 The decay of the barium current (IgJ is also not complicated by the presence of calcium-dependent inactivation. 2728 Lastly, the measurement of IB, was not contaminated by the presence of a transient outward current sensitive to 4-aminopyridine as was the case for I c (data not shown). For these reasons, IB, was studied in 90 different cells, while I c was studied in only 12 cells.
Previous studies have described the current carried by L-type VSCCs as declining in magnitude with time, so-called rundown. 26 To quantitate accurately the effects of the drugs, a diary of Io, or IB, magnitude with time after initiation of internal dialysis was kept. For all experiments, a 100-msec test pulse to +20 mV from the holding potential of -60 mV was given every 20 seconds, and the peak Ic, or IB, as a function of time was plotted (see Figures 1, 5 , and 8 for examples). A wide range of rates of current rundown was observed in the different cells. In the best cases, little if any detectable current decline was present after up to 1 hour of recordings. In the worst cases, current could decline as rapidly as 10%/min. Immediately after breaking through the cell membrane, a rapid change in I c or IB, could sometimes be observed, lasting generally less than 2 minutes. After this initial period, the currents changed much more slowly. A cell was used in a drug experiment only if the rate of current rundown was 2%/min or less. Since drug action reached a steady state within 2 minutes at most concentrations tested, effects of rundown were negligibly small over that time period. Thus, in measuring the effect of the drugs on peak current, no correction was made for rundown because only cells with slow rates of rundown were tested.
Data Analysis
The cell capacitance was determined by integrating the area under a capacity transient of a 10 mV depolarizing test pulse to a potential that did not evoke any time-dependent current (generally from -60 mV to -50 mV).
For inactivation pulse protocols, the data were fit with a nonlinear least-squares regression analysis to a Boltzmann distribution:
where I is the peak inward current measured with the test pulse, I^ is the fit maximum peak inward current for the test pulse, V m is the prepulse potential, V l/2 is the potential of half inactivation, k is the slope factor of the curve, and L^,, is the maintained current component, which did not inactivate.
To fit the activation curves for I Bl , leaksubtracted current records were used to calculate the conductance (g) at each test potential by dividing the peak IB, by the driving force ( V m -V J . Leak current was measured after complete block of IB. with 1 mM CdCl 2 . The conductance values were then fit to the Boltzmann distribution as described above using the following equation:
g=-
Smax
Data are presented as mean value ±SEM unless ±SD indicated.
Drugs
The isolated enantiomers of 202-791 were kindly supplied by Dr. R.P. Hof, Sandoz Ltd, Basel, Switzerland. DHPs were dissolved in absolute ethanol to make 10 mM stock solutions. The final concentration of ethanol present had no detectable effect on the magnitude or kinetics of IB, up to 0.04% ethanol (equivalent to that present for the highest concentration of DHP tested, 4 /xM).
Results
Characterization of /&, in Guinea Pig Ventricular Myocytes
The study of IB, or I^ is complicated by the fact that multiple types of VSCCs have been documented in many tissues including mammalian ventricular myocytes. 29 -31 According to the nomenclature of Nilius et al, 30 two types of VSCCs have been demonstrated in ventricular myocytes; the T and L channels. The magnitude of the peak current carried by T-type VSCCs in both guinea pig and canine ventricular cells has been found to be substantially less than that carried by L-type VSCCs. 29 - 31 In addition, one study has documented that higher divalent cation concentrations (^10 mM Ca) are required to be able to clearly detect T-type channels in whole cell voltage clamp experiments using guinea pig ventricular myocytes. Under the conditions employed in the present experiments (1.8 mM Ca or Ba) no evidence for T-type VSCCs was observed. Current-voltage (I-V) curves did not show an initial "hump," nor did the inactivation curves suggest the presence of two populations of channels. Previous studies have also shown that it is only the L-type VSCCs that are highly sensitive to modulation by DHPs. 29 -31 In the present study, inward •Current density was calculated by measuring the inward current in response to a depolarizing test pulse to +20 mV from a holding potential of -6 0 raV and dividing this by the whole-cell capacitance. Current density was determined within 5 minutes after rupture of the cell membrane after the current had achieved a stable state. tCurrent-voltage relations were measured from a holding potential of -6 0 mV and test pulse were given in 8 mV steps. The peak of the current-voltage was defined as that test potential that resulted in the largest inward current.
$Inactivation pulse protocols were carried out as described for Table 1 describes some of the properties of 1ô bserved under control conditions. An indirect evaluation of myocyte size was obtained by measuring whole cell capacitance. The whole cell capacitance reflects the total sarcolemmal surface area, which includes the T tubular and surface sarcolemma. The average whole-cell capacitance was 85.2±22.1 pF (±SD) for the 90 cells tested. A typical cell isolation from a single guinea pig heart resulted in a range of different sized cells, and guinea pigs ranging in size from 200-300 g were employed, which also contributed to the variability in cell size. 32 Current density was calculated by dividing the peak inward Ig, obtained from a test pulse to +20 mV from a holding potential of -60 mV by the whole cell capacitance for an average value of 6.02±2.37 pA/ pF (±SD). This variability in current density was not clearly related to the time following isolation, whole cell capacitance, potential at the peak of the I-V relation, or V m for the inactivation curve (data not shown).
Onset of Action of(+)-202-791
The onset of action of (+)-202-791 on VSCCs was examined under three different conditions shown in Figure 1 . The onset was examined when the holding potential was held at -60 mV with depolarizing test pulses to +20 mV every 20 seconds as shown in Figure 1A . It can be seen that 0.04 /xM (+)-202-791 caused a rapid increase in the peak In, and a much faster decay of the current during the test pulse compared to control (shown in the inset). (+)-202-791 also slowed the deactivation of 1^, as the tail current is slower in the presence of the drug than in the control (see current traces in Figure 2 for a clearer demonstration of this effect). The changes in IB, induced by (+>202-791, including an increase in peak current, faster decay of the current, and slower deactivation, are typical of the changes induced by calcium channel agonists. 15 - 3334 The changes in IB, at this concentration of (+)-202-791 essentially reached a steady state within 2 minutes of applying the drug to the chamber.
The next question examined was whether the presence of depolarizing test pulses during exposure of a cell to (+)-202-791 affected the onset of action. Figure IB shows that if the same concentration of (+)-202-791 (0.04 /xM) was perfused through the chamber in the absence of depolarizing pulses that a steady-state agonist effect was still achieved within 2 minutes. Depolarizing test pulses (and presumably channel openings of the VSCCs) are not required for the onset of action of (+)-202-791. One other important feature of Figure IB is that the current measured in this case was Io-The difference between IN, and I c is evident in the faster current decay in the presence of calcium under control conditions (compare control currents in Figures 1A and IB) ; however, the steady-state effect of (+)-202-791 on the peak current is quite similar with both charge carriers.
The onset of action of (+)-202-791 was measured from a holding potential of -30 mV, rather -60 mV. Figure IC reveals that the effect of the drug under these conditions was complex. First, a transient increase in the peak current was observed which rapidly declined until a steady-state level of block was obtained. Thus, the "pure" agonist enantiomer of 202-791 was capable of blocking 1^ at depolarized holding potentials. A strong voltage-dependence of the action of this agent was made evident by these simple experiments, and so further studies were designed to more closely examine this phenomena.
Peak Current-Voltage Relations at Two Holding Potentials
To determine the effect of (+)-202-791 on 1ê licited over a range of test potentials, peak I-V relations were measured in the presence and absence of 0.4 fjM (+)-202-791. From a negative holding potential of -60 mV, (+)-202-791 increased the peak IB, at all potentials tested (Figure 2A ). The peak of the I-V relation was only slightly shifted in the hyperpolarizing direction in the presence of (+)-202-791 in this experiment, but other I-V curves more clearly show a shift in the peak of the curve as has also been observed with other DHP agonists. 15 -3334 Again the striking effect of (+)-202-791 on the kinetics of 1^ are evident from the current traces shown. A much faster decay of the inward current coupled with a slower tail current resulted in the presence of (+)-202-791. In striking contrast to the effects observed on the I-V curves elicited from a holding potential of -60 mV, the I-V curves obtained from a holding potential of -30 mV showed a different pattern of drug action on la, ( Figure 2B ). At most test potentials 0.4 fiM (+)-202-791 blocked IB, relative to control. Thus, the single enantiomer (+)-202-791, is capable of both increasing or decreasing I&, depending on the holding potential. At a holding potential of -30 mV, (+)-202-791 reproducibly resulted in a persistent inward holding current, which could be rapidly eliminated by changing the holding potential to -60 mV. This persistent inward holding current could have resulted from a hyperpolarizing shift in the voltage dependence of activation of the VSCCs in the presence of (+)-202-791, leading to the activation of significant 1^ at -30 mV. Therefore, a closer examination of changes in the voltage dependence of activation by this agent was performed.
Voltage Dependence of Activation
To accurately examine the effect of (+)-202-791 on VSCC activation, leak currents were also measured by adding 1 mM CdCl 2 to totally block the current through VSCCs as shown in Figure 3A . In this cell, 1 FIM (+)-202-791 caused a hyperpolarizing shift in the peak of the I-V relation with no change in the observed reversal potential (+57 mV) (also see Sanguinetti et al 15 for similar results with racemic Bay K 8644). The leak corrected data were used to calculate the conductance (g) at each test potential by dividing the peak inward current by the driving force (V-V rev ). In Figure 3B , the normalized conductance as a function of membrane potential is plotted to determine the drug induced shift in the voltage dependence of VSCC activation. The shift in the V 1/2 induced by 1 fiM (+>202-791 in this cell was -10 mV. The average shift in the V w for activation of VSCCs induced by 1 /AM (+)-202-791 in four different cells was -8.5±1.6 mV.
lnactivation Measured With Brief Prepulses
The previous experiments employing different holding potentials suggested that the holding or resting membrane potential plays a pivotal role in determining the effect of (+)-202-791 on I^. By carrying out a typical inactivation pulse protocol in effect after a prepulse to -50 mV is shown in Figure  4C while a much smaller effect is seen after a prepulse to -10 mV shown in Figure 4D . The normalized inactivation curves, shown in Figure  4B , demonstrate that 1 /xM (+)-202-791 shifted the Vm for inactivation of IB. in the hyperpolarizing direction by 11.9 mV in this cell. It is also important to note that no change in the slope of the curve under the two conditions was observed. This shift in V 1/2 contributes to the greatest increases in IB, being observed at hyperpolarized potentials where no significant inactivation occurs. Using a 1-second prepulse protocol, "crossover" of the inactivation curves was never observed when the presence of rundown was ruled out. It is important to realize that the two earlier experiments demonstrating a block of IB. at depolarized holding potentials (Figures 1C and 2B) were carried out with the membrane potential maintained at a depolarized level for minutes rather than 1 second. Longer prepulses were not employed in the present study because they resulted in substantial acceleration of the rundown process in most cells.
Concentration-Effect Relations
It has been demonstrated that (+)-202-791 alters the magnitude and the kinetics of IB,. The concentration range over which (+)-202-791 exerts these effects on IR, was examined. First, in stable cells (no significant rundown of IBJ multiple concentrations of (+)-202-791 were tested to obtain a concentrationeffect relation for the increase in peak current using a single cell as shown in Figure 5A . This result clearly showed that there was a concentrationdependent increase in the magnitude of IB, when the holding potential was -60 mV. The problem encountered with testing multiple concentrations in a single cell was that often rundown becomes a significant factor, so normally only one or two concentrations were tested per cell. The averaged data for the concentration-effect relation of (+)-202-791 on peak IB, measured from a holding potential of -60 mV 
[(+)-202-791] (M)
are displayed in Table 2 . The concentration-effect data is further divided into those experiments employing cells used on the day of isolation (day 1) and the following day (day 2). It is interesting to note that day 2 cells displayed a wide range of responses to a given concentration of (+)-202-791 resulting in significant scatter of the concentrationeffect data for day 2 cells as well as the averaged data for all the cells tested. However, the data from cells used on the day of isolation demonstrated a clear concentration-dependent saturable increase in I B , in response to (+)-202-791, which could be well described by assuming a simple one-to-one drug receptor interaction as shown in Figure 5B with a maximum effect of a 3.56-fold increase in peak IB, and an EC^ of 1.77xlO~7 M. The reason for the greater cell to cell variability in response to (+)-202-791 in day 2 compared with day 1 cells is not clear, but certainly could be related to variable changes in intrinsic modulators of DHP sensitive VSCCs following isolation. The concentration dependence of the shift in the V, /2 of the inactivation curves induced by (+)-202-791 was also examined. The average data for all the cells tested is also shown in Figure 5B . (+)-202-791 induces a concentration-dependent hyperpolarizing shift in the V^, which saturates at about 0.4 /iM. The curve drawn through the data points is again that for a simple one-to-one drug receptor interaction that shows a maximum shift of -9.91 mV and an EQo of 1.02xl0~8 M. Interestingly, the EC50 for this effect is 17-fold lower than the EC50 for the increase in the peak I B , (compare the two curves in Figure 5B ). No significant differences were observed for the shift in the V 1/2 for day 1 versus day 2 cells (see Table 3 ). Thus, all of the data was averaged and included in Figure 5B to calculate the EC30 for the shift in V m . Figure 6 displays the results of an experiment designed to test for frequency-dependent effects of (+)-202-791. In this experiment, both 20 msec and Note fractional increase in peak la. was calculated from current records without leak subtraction. Day 1 cells, cells used on the day of isolation; Day 2 cells, cells used the following day. Cell data are fractional increments ±SD. Shift in V w was calculated from inactivation curves using a 1-second prepulse as described in "Materials and Methods." 200 msec voltage-clamp pulses from a holding potential of -60 mV to a test potential of +20 mV were applied at a frequency of 2 Hz in the absence and presence of 1 /iM (+)-202-791. Under control conditions, the magnitude of the peak I&, declined slightly after 15 pulses; however, in the presence of 1 ^.M (+)-202-791 there was a dramatic decline in the peak Is, during the train of 15 depolarizing pulses. The development of "relative block" was most pronounced with the 200-msec pulse trains. The peak current measured in the presence of the drug after the 15th pulse closely approached the control value. This frequency dependence is quite similar to the results predicted by slow response action potential studies for both CGP 28 392 and (+)-202-791. 1621 In addition, the frequency dependence of the action of (+)-202-791 is comparable to that observed for racemic Bay K 8644. l5 The striking frequency-dependent blocking action observed in the presence of the drug suggested that the recovery from inactivation after a depolarizing test pulse was slowed by (+)-202-791.
Frequency-Dependent Effects of (+)-202-791
A standard two-pulse protocol was used to measure the rate of recovery from inactivation of 1^. A 500-msec prepulse to -15 mV was applied, followed by a variable recovery time at -60 mV. Then, a test pulse to +20 mV was applied to determine the relative amount of current present. Under control conditions, the recovery of the current could be well fit by a single exponential, while in the presence of 1 fjM (+)-202-791 the recovery process was better described by a double exponential fit as displayed in Figure 7 . This experiment is representative of six such experiments, and the average T^^yay was 0.349±0.032 seconds under control conditions. In the presence of 1 /xM (+)-202-791, the average Tŵ as 0.329±0.069 seconds and T^^ was 2.509±0.234 seconds. The fraction of current that recovered slowly in the presence of 1 /nM (+)-202-791 averaged 56.7±6.3% of the total.
Effect of (±)-202-791 on /*,
The studies of the modulation of IB, thus far have concentrated strictly on the effect of (+)-202-791. Our earlier slow response studies indicated that (-)-202-791 and racemic (±)-202-791 acted as a calcium antagonist, reducing V^ presumably by blocking VSCCs. 21 A recent study has examined the effect of various combinations of ( + )-and (-)-202-791 on the single channel behavior of VSCCs." This study found that in cells with a normal resting potential (about -38 mV for cultured neonatal rat ventricular cells), the combination of the (+) and (-) enantiomers revealed positive cooperativity resulting in an enhancement of the open state probability of the channels compared to that observed with the (+) enantiomer alone. These findings were taken as strong evidence for the existence of at least two high-affinity DHP binding sites associated with VSCCs, which under appropriate conditions can show striking cooperative interactions. With these findings in mind, the next experiments were designed to determine if positive cooperativity between the enantiomers of 202-791 could be observed with whole-cell recordings of IB,. these cells did addition of the (-) enantiomer to a cell equilibrated with a given concentration of the (+) enantiomer lead to a clear increase in IB.. AS the study of Kokubun et al" employed 45 mM Ba compared with the above results with 1.8 mM Ba, two experiments were carried out using 45 mM Ba. Again, no cooperative interactions between the enantiomers of 202-791 were observed (data not shown).
Discussion
Membrane Potential Determines if (+)-202-791 Enhances or Inhibits 1Â
major finding of this work was that (+)-202-791 can either increase or decrease peak IB,, depending on the membrane potential at which the cell is maintained. At hyperpolarized potentials the "agonist" activity of this agent was greatest, resulting in up to a 3.5-fold increase in peak 1^. The onset of this effect apparently does not require channel opening as similar rates of onset were observed in the presence or absence of depolarizing voltage steps. In contrast, if the cell was maintained at depolarized potentials (approximately ^-30 mV), then (+)-202-791 blocked peak I^. The onset of drug action at depolarized potentials was complex, with an initial transient increase in IB, followed by a decrease to a steady state blocked level. A biphasic onset of drug action was also described for racemic nitrendipine in studies of whole cell currents 19 or single channel currents. 3 Perhaps these two agents may share the same basic mechanism of action even though one is regarded as a calcium channel agonist and the other a calcium channel antagonist.
A typical inactivation pulse protocol was used to more precisely define the voltage dependence of the action of (+)-202-791. Using a 1-second prepulse, the effect of (+)-202-791 to increase 1^, was greatest following negative prepulse potentials and much less following more depolarized prepulse potentials. This was reflected by a concentration-dependent shift in the midpoint of the inactivation curves by (+)-202-791. Our results using the inactivation pulse protocol do not demonstrate block, but other experiments that maintained the membrane potential at a depolarized level for minutes rather than 1 second demonstrated significant block. Thus, the time a cell is maintained at a depolarized membrane potential seems to play a critical role in determining whether (+)-202-791 will block 1^ and in the magnitude of the shift of the V l/2 for inactivation. In support of this idea, a single channel study that examined the effect of (+)-202-791 on the voltage dependence of VSCC inactivation found that 1 /iM (+)-202-791 caused a substantial block of the ensemble averaged IB» at depolarized potentials and shifted the V 1/2 of the availability curve by -36 mV." Sanguinetti et al 15 demonstrated that 500-msec prepulses in the absence and presence of racemic 500 nM Bay K 8644 resulted in a significant "crossover" of the inactivation curves, resulting in block at positive potentials and an average shift of the V| fl of -11 mV. The results of that study with (±>Bay K 8644 were modeled by a scheme that assumed this drug caused a concentration-dependent slowing of the rate constant controlling single calcium channel transitions from the open to the closed (rested) state. Unfortunately, the interpretation of those results was complicated by the presence of opposing enantiomers. More recent studies with the agonist enantiomer (-)-Bay K 8644 have confirmed the fact that this compound alone can result in block of Ic if the cell is maintained at more positive holding potentials. 35 However, one study of inactivation of whole-cell I c after 30-second prepulses did not demonstrate block at depolarized potentials by either (+)-202-791 or (-)-Bay K 8644. In summary, the majority of evidence demonstrates that the isolated agonist DHP enantiomers (+)-202-791 and (-)-Bay K 8644 can greatly enhance current through VSCCs at hyperpolarized potentials, but can block it at depolarized potentials.
Concentration Dependence of(+)-202-791 Action
At a holding potential of -60 mV, (+)-202-791 resulted in a concentration-dependent increase in the peak 1^ with an EC^ of 1.77xlO" 7 M. This value compares well with the EC50 values deter-mined by others for this agent. 7 - 22 Many earlier studies employing racemic Bay K 8644 in a variety of tissues observed bell-shaped concentration-effect relations. 1718 More recent studies measuring the contraction of smooth muscle have clearly shown bell-shaped concentration-effect relations for the single enantiomers (+)-202-791 and (-)-Bay K 8644.
M Likewise, a bell-shaped concentration-effect relation for the positive inotropic effect of (+)-202-791 on canine ventricular trabeculae has been observed. 22 In contrast to these results, the present study and that of Williams et al 22 observed a simple saturable concentration-effect relation with no evidence of block of Ig, or IQ, at higher concentrations using isolated guinea pig ventricular myocytes. It is intriguing that studies of intact tissues clearly showed bell-shaped concentration-effect relations, while the present study and that of Williams et al 22 used the whole-cell, patch-clamp technique, which results in dialysis of the cell cytosol with the pipette solution. The significance of these different results remains to be determined.
The results also demonstrated that the shift in the midpoint of the inactivation curves in response to (+)-202-791 was concentration-dependent. The concentration dependence of this effect occurs at concentrations 17-fold lower than the concentrations that increase peak IB». A concentration-dependent and saturable hyperpolarizing shift in the V l/2 of the inactivation curve can be described by the modulated receptor hypothesis 3738 as resulting from differences in the binding affinity of drugs to different states of a channel. The premises of such a hypothesis include the idea that drug binding is equivalent to blockade of the channel, yet clearly in the case of calcium channel agonists, drug binding may result in the opposite effect. Nevertheless, it seems equally plausible that DHP agonists can bind with variable affinity to different states of the VSCC. For example, the 17-fold difference in the EC50 for the shift in V 1/2 compared with the EC50 for agonist effect on peak 1^ may be related to the fact that (+)-202-791 is binding almost exclusively to channels in the resting state at -60 mV for the assay measuring the increase in peak I^, whereas the effect of (+)-202-791 on V 1/2 could reflect binding of drug to resting state as well as higher affinity binding to channel states favored at depolarized potentials such as the open or inactivated state.
Frequency-Dependent Effects of(+)-202-791
The present voltage-clamp studies confirmed the findings from our previous slow response studies 16 -21 that the ability of DHP agonists to increase current through VSCCs is diminished at higher stimulation rates. Furthermore, the longer the depolarizing pulse, the more marked the decline in peak Ig,. Use or frequency dependence has been hypothesized to occur in the case of channel blocking drugs for a number of possible reasons. One hypothesis involves the idea that repeated depolarizing pulses cause channels to cycle between resting, open, and inactivated states. If the affinity of a drug is much greater for inactivated channels than resting channels, then significant drug binding may occur during depolarizing steps, even though little drug was bound under the resting conditions. If during a train of depolarizing voltage pulses, the unbinding of the drug upon returning to the negative resting potential takes more time than is available between pulses, then block will accumulate until a steady-state level is reached which is critically related to the pulse duration, interpulse interval, and the binding properties of the drug. 37 - 38 The ability of block to accumulate in such a manner can be examined by measuring the time course of recovery of current after a depolarizing pulse, and several DHP calcium antagonists have been shown to induce a slowing of recovery.
910 - 19 In the present study, (+)-202-791 induced a second slower recovery process resulting in a biexponential recovery, with the slower phase perhaps resulting from slow recovery from drug block of calcium channels. However, a simple interpretation of this experimental observation similar to that for the channel blockers is obviously not possible, since at negative membrane potentials, significant binding of (+)-202-791 must occur as evidenced by its agonist effect. Thus, in the case of (+)-202-791, binding cannot be equated with channel block as hypothesized for the calcium channel antagonists. 91019 If one assumes that the fast recovery phase in the presence of (+)-202-791 represents the recovery of drug-free channels, then what does the slowly recovering fraction of 1^ represent? One possibility is that additional drug binding occurs during the depolarizing pulses, perhaps to a second site. Binding to this site could be favored at depolarized potentials and result in block of channels. The slow recovery phase in the presence of (+)-202-791 could be related to the unbinding of the drug from this second site.
Evidence for Multiple DHP Binding Sites
Since the discovery of DHP calcium channel agonists, it has been debated whether one or more DHP binding sites are associated with VSCCs. Some investigators have favored schemes viewing DHPs as binding to a single site with different intrinsic activities, regarding them as agonists, partial agonists, or antagonists in analogy with the pharmacology of hormone receptors. 39 Others have favored models discussing two distinct DHP binding sites associated with VSCCs. 111718 Recently, one study has provided convincing evidence for a second functional DHP binding site. 11 These authors described an enhancement of 3 H-PN200-110 binding by (+)-202-791 that could not be explained by a simple 1:1 competition for the same binding site. This positive cooperativity was evident at hyperpolarized potentials, but it was not present under depolarized conditions. In addition, these investigators provided electrophysiological evidence for coop-erative interactions between the enantiomers of 202-791 on single channel activity of VSCCs. It was postulated that there are two distinct dihydropyridine binding sites, an activator and a blocker site, which can be bound preferentially by (+)-202-791 and (-)-202-791, respectively." In contrast, the present study failed to detect any evidence for cooperative interactions between the enantiomers of 202-791. The possible reasons for these conflicting results include differences in preparations (cultured neonatal rat ventricular myocytes versus guinea pig ventricular myocytes), recording techniques (singlechannel versus whole-cell, patch-clamp), and holding potential (-38 mV versus -60 mV).
On the other hand, certain experimental findings observed in the present study could be interpreted as consistent with the presence of multiple DHP receptors. For example, the transient increase and then block of 1^ by (+)-202-791 when added to a cell maintained at a depolarized potential is difficult to explain by a simple single-binding site model; however, the binding of (+)-202-791 to multiple sites could easily explain such a biphasic effect. Furthermore, the use and voltage-dependent effects of (+)-202-791 can also be easily interpreted using a multiple-binding site scheme as discussed. While experimental evidence is beginning to accumulate in support of multiple DHP binding sites, many questions about molecular properties of these sites remain. For example, how different are these two receptors given that the structural properties of the ligands that can differentiate between them are subtle, that is, the difference between stereoisomers? Are the different receptors located on different subunits of the VSCC? Could allosterically interacting DHP binding sites be reflecting the repeated presence of a given DHP binding subunit in a multimeric protein structure?
